Engineered natural killer cells may be the next great cancer immunotherapy

The cancer fighters known as CAR T cells have proved their prowess in recent years. Three therapies using the altered T cells against lymphoma or leukemia have won U.S. Food and Drug Administration approval, and hundreds of trials are now unleashing them on other malignancies, including solid tumors.


Leave a Reply

Your email address will not be published. Required fields are marked *